NEPH — Nephros, Inc.

Nephros Inc. Q4 2025 Earnings Call Summary

1. Key Financial Results and Metrics:

• Q4 2025 Revenue: $4.7 million, a 22% increase year-over-year.
• Full Year 2025 Revenue: $18.8 million, up 33% from $14.2 million in 2024.
• Net Income: $1.2 million for the year, compared to $0.1 million in 2024; Q4 net income was $0.1 million, down from $0.3 million in Q4 2024.
• Gross Margin: 62% for the full year; Q4 gross margin was 58%, down from 64% in Q4 2024, primarily due to tariffs.
• Adjusted EBITDA: Q4 was $131,000 (down from $481,000 in Q4 2024); full-year adjusted EBITDA was $1.6 million, up from $548,000 in 2024.
• Cash Position: $5.4 million at year-end, up from $3.8 million a year earlier; the company remains debt-free.

2. Strategic Updates and Business Highlights:

• Nephros is focusing on three core pillars: Products, Services, and Education.
  • Products: Launched new filtration technologies for various applications beyond healthcare, including ice machines and drinking fountains.
  • Services: Expanded installation and maintenance capabilities to enhance customer relationships and create recurring revenue streams.
  • Education: Established the Nephros Water Institute, conducting webinars and training to promote water safety and filtration solutions.
• Active customer sites grew to 1,681, up from 1,500 in 2024, reflecting strong customer retention and outreach efforts.

3. Forward Guidance and Outlook:

• Nephros anticipates continued growth driven by increasing awareness of waterborne pathogens and regulatory demands for water safety.
• The company is optimistic about expanding into non-medical markets, although it acknowledges that this will be a multi-year strategy requiring ongoing education and relationship-building.

4. Bad News, Challenges, or Points of Concern:

• Margin Pressure: Gross margins declined in the second half of 2025 due to tariffs on imported goods from Italy, which were recently reduced but still pose uncertainty.
• Net Income Decline in Q4: Although the company achieved profitability for the second consecutive year, net income decreased in Q4 compared to the previous year, attributed to rising expenses and lower gross margins.
• Regulatory Environment: The unpredictability of U.S. tariff policies creates potential risks for future margins.

5. Notable Q&A Insights:

• Programmatic Sales: Over 90% of revenues were from programmatic sales in both Q4 and the full year, indicating strong demand for recurring revenue models.
• Market Expansion: Management highlighted successes in non-patient care markets, including correctional facilities and educational institutions, emphasizing the importance of education in driving adoption.
• Sales Growth: The company is leveraging customer referrals and outreach at conferences to expand its customer base, indicating a strong focus on customer satisfaction and retention.

Overall, Nephros demonstrated solid revenue growth and profitability in 2025, while strategically positioning itself for future expansion into new markets. However, it faces challenges related to margin pressures and the need for continued education to penetrate non-medical sectors effectively.